Effect of vitamin E in preventing kidney problems in thalassemia patients

Phase 3

• Conditions: N17.0; E72.0; R94.4; Condition 1: Thalassemia. Condition 2: Acute Kidney Injury. Condition 3: Fanconi syndrome. Condition 4: Abnormal Kidney function.; Beta thalassemia; Acute kidney failure with tubular necrosis; Disorders of amino-acid transport; Abnormal results of kidney function studies; D56.1

• Registration Number: IRCT20221111056466N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

All patients with thalassemia are covered by Amir Kabir Arak Hospital

Exclusion Criteria

All patients who are covered by Amirkabir Hospital but do not consent to participate in the study.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Creatinine level. Timepoint: It will be checked on the first day of the study and 48 hours and 7 days after the start of the study. Method of measurement: blood samples.;Glomerular filtration rate. Timepoint: It will be checked on the first day of the study and 48 hours and 7 days after the start of the study. Method of measurement: blood sample.;Blood phosphorus level. Timepoint: It is checked on the first day of the study and 30 days after the start of the study. Method of measurement: blood sample.;Urine glucose level. Timepoint: It is checked on the first day of the study and 30 days after the start of the study. Method of measurement: urine sample.;Venous blood gas level. Timepoint: It is checked on the first day of the study and 30 days after the start of the study. Method of measurement: blood sample.;The ratio of blood urea nitrogen to creatinine. Timepoint: It is checked on the first day of the study and 30 days after the start of the study. Method of measurement: blood sample.